Fingerprint
Dive into the research topics of 'Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically